Final analysis of the Neotorch study: perioperative toripalimab in combination with chemotherapy for patients with stage Ⅱ/Ⅲ resectable non-small-cell lung cancer ☆
Final analysis of the Neotorch study: perioperative toripalimab in combination with chemotherapy for patients with stage Ⅱ/Ⅲ resectable non-small-cell lung cancer ☆. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426068754?dgcid=rss_sd_all
Final analysis of the Neotorch study: perioperative toripalimab in combination with chemotherapy for patients with stage Ⅱ/Ⅲ resectable non-small-cell lung cancer ☆. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426068754?dgcid=rss_sd_all
“Final analysis of the Neotorch study: perioperative toripalimab in combination with chemotherapy for patients with stage Ⅱ/Ⅲ resectable non-small-cell lung cancer ☆.” Annals of Oncology.
@article{article35989,
title = {Final analysis of the Neotorch study: perioperative toripalimab in combination with chemotherapy for patients with stage Ⅱ/Ⅲ resectable non-small-cell lung cancer ☆},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426068754?dgcid=rss_sd_all}
}